Fulgent Genetics (FLGT) Short term Debt (2020 - 2026)

Fulgent Genetics (FLGT) has 7 years of Short term Debt data on file, last reported at $30.6 million in Q1 2026.

• Quarterly Short term Debt rose 10.56% year-over-year to $30.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.6 million (up 10.56% YoY) and the FY2025 annual result came in at $28.1 million, up 1.94% from the prior year.
• Short term Debt advanced to $30.6 million in Q1 2026 per FLGT's latest filing, from $28.1 million in the prior quarter.
• The five-year high for Short term Debt was $30.6 million in Q1 2026, with the low at $10.9 million in Q4 2022.
• Average Short term Debt over 5 years is $23.0 million, with a median of $26.9 million recorded in 2024.
• Year-over-year, Short term Debt surged 4945.12% in 2022 and sank 50.07% in 2023.
• Fulgent Genetics' Short term Debt stood at $10.9 million in 2022, then soared by 108.35% to $22.7 million in 2023, then climbed by 21.63% to $27.6 million in 2024, then rose by 1.94% to $28.1 million in 2025, then advanced by 8.79% to $30.6 million in 2026.
• Business Quant data shows FLGT's Short term Debt at $30.6 million in Q1 2026, $28.1 million in Q4 2025, and $28.5 million in Q3 2025.